30.10.2024
SYMPOSIUM 1 - LILLY
Time: 16:15 - 17:00
Hall: Congress Hall
TBC
31.10.2024
SYMPOSIUM 2 - ZENTIVA
Treatment of cardiovascular continuum 2024: focus on novel opportunities
Time: 13:00 - 14:30
Hall: Congress Hall
Chair: R. Češka
L. Tokgözoğlu (Ankara, Turkey) LDL-C and Lp(a)
A. Zambon (Padova, Italy) Lipids
K. Narkiewicz (Gdansk, Poland) Hypertension and obesity
SYMPOSIUM 3 - DIGITAL MEDICINE
Time: 14:30-15:30
Room: Panorama Hall
I. Said Criado (Ponteverda, Spain) - New Skills to adress Digital Medicine
M. Prázný (Prague, Czech Republic) - Digital diabetology: fiction or reality?
J. Škrha jr. (Prague, Czech Republic) - Can AI help in the postgraduate education and research?
SYMPOSIUM 4 - WORWÄG PHARMA
The many faces of B12-deficiency and necessity of multidisciplinary management
Time: 14:30 - 15:30
Hall: South Hall 1
R. Češka (Prague, Czech Republic) Optimizing Patient Care: Strategies for Managing Vitamin B12 Deficiency in Internal Medicine
R. Obeid (Hamburg, Germany) Practical Guidance for Diagnosing and Treating Vitamin B12 Deficiency: Results of an International and Multidisciplinary B12 Consensus Conference
B. Hooshmand (Tutzing, Germany) Vitamin B12 in Neurology: A Clinical Approach
Invitation for the symposium here
SYMPOSIUM 5 - SANOFI
Comprehensive management of post ACS patients – how to improve and optimize secondary prevention?
Time: 15:30 - 16:30
Hall: Panorama Hall
Chair: R. Češka
A. Linhart (Prague, Czech Republic) - Dyslipidemia - an underappreciated risk factor in the context of a high-risk country
M. Vrablík (Prague, Czech Republic) - Fail no more. Lipid goals at our hands.
M. Kaluzna-Oleksy (Poznan, Poland) - Complex ACS management - the place of lipid lowering therapy and rehabilitation – learnings from MACAMIS program in Poland - ACS forum like an experience exchange platform
SYMPOSIUM 6 - ISIM
Time: 15:30 - 16:30
Hall: South Hall 1
C. Arias (Santo Domingo, Dominican Republic) Monkeypox
Q. T. Islam (Dhaka, Bangladesh) Emergencies in Dengue Syndrome
A. C. Cejudo (Mexico City, Mexico) Inflammatory process and the risk factors for cardiovascular diseases
E. Topinková (Prague, Czech Republic) Geriatrics
1.11.2024
SYMPOSIUM 7 - AMGEN
Time: 13:00 - 14:30
Hall: Congress Hall
Chair: R. Češka
R. Češka (Prague, Czech Republic) - Introduction
L. Tokgözoğlu (Ankara, Turkey) - CV risk reduction with lipid lowering: When and how?
M. Vrablík (Prague, Czech Republic) - The Power of Low LDL-C: Who Benefits Most and How Low is Enough
A. Zambon (Padova, Italy) - From research to clinical settings: PCSK9i Real Life Experience in Europe
Invitation for the symposium here
SYMPOSIUM 8 - NOVARTIS LP(a)
Session 1 - Elevated Lp(a)
Time: 14:30 - 15:30
Hall: Panorama Hall
Chairs: M. Vrablík, R. Češka
L. Tokgozoglu (Ankara, Turkey) ...The global problem
A. Zambon (Padova, Italy) ... and CVD risk
P. Lansberg (Amsterdam, Netherlands) ... and therapeutic approach
Session 2 - Lp(a): policies, best practices and tips to enhance acceptance
Time: 15:30 - 16:30
Hall: Panorama Hall
Chair: M. Vrablík
M. Banach (Lodz, Poland)
R. Češka (Prague, Czech Republic)
K. Čillíkova (Czech Republic)
P. Lansberg (Amsterdam, Netherlands)
M. Rizzo (Palermo, Italy)
L. Tokgozoglu (Ankara, Turkey)
A. Zambon (Padova, Italy)
Topics to be discussed:
- To screen or not to screen for Lp(a) levels: roles of national and EU CVD plan
- When and how
- Examples of good practices
- How not to lose the information on elevated Lp(a)
- How to explain the topic to colleagues and patients
- Which examinations and how frequently should be done in patients with elevated Lp(a) levels
- While we are awaiting the specific drugs targeting Lp(a) what shall we do to reduce the burden of elevated Lp(a) levels
PRAGUE - THE CAPITAL OF INTERNAL MEDICINE 2024